Reversal of a Vigilance Decrement in the Aged Rat by Subtype-Selective Nicotinic Ligands (original) (raw)
Benwell MEM, Balfour DJK (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol105: 849–856. ArticleCASPubMedPubMed Central Google Scholar
Blondel A, Sanger DJ, Moser PC (2000). Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology149: 293–305. ArticleCASPubMed Google Scholar
Blondel A, Simon H, Sanger DJ, Moser PC (1999). Characterisation of the receptor subtypes mediating the effects of nicotine in the 5-choice reaction time task. J Psychopharmacol13(Suppl.): P160, A50. Google Scholar
Carli M, Robbins TW, Evenden JL, Everitt BJ (1983). Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats: implications for theories of dorsal bundle noradrenergic function based on selective attention and arousal. Behav Brain Res9: 361–380. ArticleCASPubMed Google Scholar
Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997). Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in xenopus oocytes. J Pharmacol Exp Ther280: 346–356. CASPubMed Google Scholar
Clarke PBS, Kumar R (1983a). The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol78: 329–337. ArticleCASPubMedPubMed Central Google Scholar
Clarke PBS, Kumar R (1983b). Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br J Pharmacol80: 587–594. ArticleCASPubMedPubMed Central Google Scholar
Conners CK, Levin ED, Sparrow E, Hinton SC, Erhardt D, Meck WH et al (1996). Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull32: 67–73. CASPubMed Google Scholar
Cosford ND, Bleicher L, Herbaut A, McCallum JS, Vernier JM, Dawson H et al (1996). (S)-(−)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem39: 3235–3237. ArticleCASPubMed Google Scholar
Gordon J, Gurley DA, Tran O, Machulskis A, Zongrone J, Luhowskylj S et al (1998). AR-R17779: the first high affinity, subtype-selective full agonist at the rodent α7 nicotinic acetylcholine receptor. Soc Neurosci Abstr24: 331.9. Google Scholar
Grottick AJ, Higgins GA (2000). Effect of subtype selective nicotinic compounds on attention as assessed by the 5-choice serial reaction time task. Behav Brain Res117: 197–208. ArticleCAS Google Scholar
Grottick AJ, Higgins GA (2002). Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants. Psychopharmacology164: 33–41. ArticleCASPubMed Google Scholar
Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R et al (2000a). Evidence that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther294: 1112–1119. CASPubMed Google Scholar
Grottick AJ, Wyler R, Higgins GA (2000b). The α4β2 agonist SIB 1765F, but not the α7 agonist AR-R17779 cross-sensitises to the psychostimulant effects of nicotine. Psychopharmacology150: 233–236. ArticleCASPubMed Google Scholar
Grottick AJ, Wyler R, Higgins GA (2001). A study of the nicotinic agonist SIB-1553A on locomotion, and attention as measured by the 5-choice serial reaction time task. Pharmacol Biochem Behav70: 505–513. ArticleCASPubMed Google Scholar
Gurley DA, Lanthorn T, Ryan T, Luhowskyj S, Gordon J (1998). Comparison of nicotine and the alpha 7-selective agonist AR-R17779 on nAchR α7 expressed in Xenopus oocytes. Soc Neurosci Abstr24: 331.10. Google Scholar
Hahn B, Shoaib M, Stolerman IP (2001). Attentional effect of nicotinic agonists in rats. Soc Neurosci Abstr31: 313.18. Google Scholar
Harvey SC, Luetje CW (1996). Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits. J Neurosci16: 3798–3806. ArticleCASPubMed Google Scholar
Louis M, Clarke PBS (1998). Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology37: 1503–1513. ArticleCASPubMed Google Scholar
Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in disease. Psychopharmacology108: 485–494. ArticleCASPubMed Google Scholar
Koelega HS (1993). Stimulant drugs and vigilance performance: a review. Psychopharmacology111: 1–16. ArticleCASPubMed Google Scholar
Levin ED, Bettegowda C, Blosser J, Gordon J (1999). AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol10: 675–680. ArticleCASPubMed Google Scholar
Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D Meck WH et al (1996). Nicotine effects on adults with attention deficit hyperactivity disorder. Psychopharmacology123: 55–63. ArticleCASPubMed Google Scholar
Luetje CW, Patrick J (1991). Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci11: 837–845. ArticleCASPubMed Google Scholar
Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK (1997). Effects of a novel cholinergic ion channel agonist SIB1765F on locomotor activity in rats. J Pharmacol Exp Ther280: 384–392. CASPubMed Google Scholar
Mirza NR, Stolerman IP (1998). Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology138: 266–274. ArticleCASPubMed Google Scholar
Parasuraman R, Davies DR (1976). Decision theory analysis of response latencies in vigilance. J Exp Psychol Hum Percept Perform2: 569–583. Article Google Scholar
Reavill C, Stolerman IP (1990). Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol99: 273–278. ArticleCASPubMedPubMed Central Google Scholar
Reid RT, Saccan AI, Adams PB, Correa LD, Santori EM, McDonald IA et al (1997). Pharmacological characterisation of SIB-1553A, a novel, subtype-selective neuronal nicotinic acetyl choline receptor (nAChR) agonist. Soc Neurosci Abstr23: 477.17. Google Scholar
Sacaan I, Reid RT, Santori EM, Addmas P, Correa LD, Mahaffy LS et al (1997). Pharmacological characterisation of SIB-1765F: a novel cholinergic ion channel agonist. J Pharmacol Exp Ther280: 373–383. CASPubMed Google Scholar
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989). The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry154: 797–800. ArticleCASPubMed Google Scholar
Sanberg PR, Silver AA, Shytle RD, Philipp MK, Cahill DW, Fogelson HM et al (1997). Nicotine for the treatment of Tourette's syndrome. Pharmacol Ther74: 21–25. ArticleCASPubMed Google Scholar
Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997). Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology129: 390–397. ArticleCASPubMed Google Scholar
Vernier JM, El-Abdellaoui H, Holsenback H, Cosford ND, Bleicher L, Barker G et al (1999). 4-[[2-(1-Methyl-2-pyrrol-idinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem42: 1684–1686. ArticleCASPubMed Google Scholar
Wesnes K, Warburton DM (1984). Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology82: 147–150. ArticleCASPubMed Google Scholar
White HK, Levin ED (1999). Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology143: 158–165. ArticleCASPubMed Google Scholar